Mitochondrial function is altered in horse atypical myopathy.
Abstract: Equine atypical myopathy in Europe is a fatal rhabdomyolysis syndrome that results from the ingestion of hypoglycin A contained in seeds and seedlings of Acer pseudoplatanus (sycamore maple). Acylcarnitine concentrations in serum and muscle OXPHOS capacity were determined in 15 atypical myopathy cases. All but one acylcarnitine were out of reference range and mitochondrial respiratory capacity was severely decreased up to 49% as compared to 10 healthy controls. The hallmark of atypical myopathy thus consists of a severe alteration in the energy metabolism including a severe impairment in muscle mitochondrial respiration that could contribute to its high death rate.
Copyright © 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
Publication Date: 2016-06-29 PubMed ID: 27374763DOI: 10.1016/j.mito.2016.06.005Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article discusses the alteration of mitochondrial function in horses due to atypical myopathy – a fatal condition often caused by consumption of toxins present in the seeds and seedlings of the sycamore maple tree.
About Atypical Myopathy and the Study
- Atypical myopathy is a deadly muscle disease in horses, most prevalent in Europe. It often results from horses consuming hypoglycin A, a toxin found in the seeds and seedlings of the sycamore maple tree (Acer pseudoplatanus).
- The focus of the study was to establish links between the disease and alterations in mitochondrial function – the part of cells responsible for generating most of their energy. This was carried out by examining serum and muscle Oxidative Phosphorylation System (OXPHOS) capacity in 15 horses diagnosed with atypical myopathy.
Key Findings
- The study found that all but one of the acylcarnitine concentrations (metabolites involved in fat metabolism) in the horses were out of their typical range. This indicates a significant metabolic disruption in the affected horses.
- In addition to this, the mitochondrial respiratory capacity – the ability of the mitochondria to produce energy – was significantly reduced, in some cases by up to 49% when compared to the 10 healthy control horses. This severe impairment suggests a potentially major role for mitochondrial dysfunction in the progression of atypical myopathy.
Conclusion
- The research illustrates that atypical myopathy in horses is strongly associated with a severe alteration in energy metabolism, more specifically, a substantial impairment in muscle mitochondrial respiration. This finding could help explain why this condition has such a high mortality rate among affected horses.
- Understanding this connection between the disease and mitochondrial function could potentially aid in developing more effective treatment and prevention strategies for equine atypical myopathy in the future.
Cite This Article
APA
Lemieux H, Boemer F, van Galen G, Serteyn D, Amory H, Baise E, Cassart D, van Loon G, Marcillaud-Pitel C, Votion DM.
(2016).
Mitochondrial function is altered in horse atypical myopathy.
Mitochondrion, 30, 35-41.
https://doi.org/10.1016/j.mito.2016.06.005 Publication
Researcher Affiliations
- Faculty Saint-Jean, University of Alberta, Edmonton, Alberta, Canada.
- Biochemical Genetics Laboratory, Human Genetics, CHU Liege, University of Liege, Belgium.
- (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
- (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium; Centre of Oxygen, Research and Development, University of Liege, Liege, Belgium.
- (c)Equine Clinic, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
- (e)Department of Animal Productions: Biostatistics, Economy and Animal Selection, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
- Department of Pathology, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium.
- (g)Large Animal Internal Medicine, Ghent University, Belgium.
- (h)Réseau d'EpidémioSurveillance en Pathologie Equine (RESPE), Caen, France.
- (i)Equine Pole, Fundamental and Applied Research for Animals and Health (FARAH), Faculty of Veterinary Medicine, University of Liege, Belgium. Electronic address: dominique.votion@ulg.ac.be.
MeSH Terms
- Acer / chemistry
- Animal Feed
- Animals
- Carnitine / analogs & derivatives
- Carnitine / blood
- Europe
- Female
- Horse Diseases / chemically induced
- Horse Diseases / pathology
- Horses
- Hypoglycins / toxicity
- Male
- Mitochondrial Diseases / chemically induced
- Mitochondrial Diseases / pathology
- Mitochondrial Diseases / veterinary
- Muscles / pathology
- Muscular Diseases / chemically induced
- Muscular Diseases / pathology
- Muscular Diseases / veterinary
- Oxidative Phosphorylation
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists